Veracyte, a cancer diagnostics company, announced it will participate in three investor conferences in November 2026: UBS Global Healthcare Conference, Jefferies Global Healthcare Conference, and Stephens Annual Investment Conference. The company will hold fireside chats at each event, sharing updates on its cancer diagnostic tests and innovations. Live audio webcasts of these presentations will be available on Veracyte's website, with replays accessible for 90 days. This participation highlights Veracyte's ongoing engagement with investors and commitment to advancing cancer care through its molecular testing platform.
Veracyte's upcoming participation in investor conferences is presented here with a snapshot of the health sector on Pluang as of Oct 30, 2026 03:11 WIB: out of 150 health-sector US stocks, 106 rose and 44 fell. Among notable movers, Eli Lilly And Co (LLY) gained 6.75% to USD 1,375.75 with a typical hold time of 94 days and a strong sell order activity of 91%. In contrast, Gilead Sciences, Inc. (GILD) rose 6.28% to USD 169.20, showing a longer hold time of 114 days and predominantly buy orders at 81%. American Well Corp (AMWL) increased 6.23% to USD 15.00 but had 100% sell order activity despite a shorter hold time of 62 days.
iHerb Holdings appointed Jordan Sweetnam, eBay's Chief Commercial Officer, as an independent director to its board. Sweetnam brings extensive experience in global eCommerce, having held senior roles at eBay and Walmart, and will support iHerb's expan...
SAP, a global enterprise software leader, will merge its North Texas operations into a new office in Addison, Texas, relocating about 1,000 employees from Plano and Allen. The new Spectrum Center location will house business operations, software deve...
Ipsos has appointed Mitch Barns as Chairman and CEO for the Americas region, effective November 2, 2026. Barns brings extensive leadership experience from his previous roles as Global CEO of Nielsen and CEO of The Opus Group, positioning him to drive...
Republic Services posted Q3 net income of $592 million, or $1.93 per share, up from $550 million a year earlier, driven by strong revenue growth and operational resilience. The company raised its full-year 2026 revenue and adjusted EBITDA guidance, r...
Miami International Holdings (MIAX) posted strong Q3 2026 results with net revenue up 20% to $131 million and adjusted EBITDA rising 47% to $70.8 million, driven by growth in its options business and increased market share. Adjusted diluted EPS impro...
